Alzheimer's disease: New data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies

Biological Psychiatry

Volumn 75, Issue 7, 2014, Pages 553-557

  Gandy, Sam ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid plaques; amyloidosis; microglia; neurodegeneration; systems biology; tauopathy

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BAPINEUZUMAB; BETA SECRETASE; BETA SECRETASE 1; BETA SECRETASE INHIBITOR; BIOLOGICAL MARKER; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; INTERLEUKIN 12; INTERLEUKIN 23; MONOCLONAL ANTIBODY; SEMAGACESTAT; SOLANEZUMAB;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; BIOLOGICAL THERAPY; BRAIN FUNCTION; CELL TYPE; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DRUG TARGETING; ENZYME INHIBITION; GENE MUTATION; HUMAN; IMMUNOTHERAPY; MICROGLIA; MOLECULE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; TAUOPATHY;

AMYLOID PLAQUES; AMYLOIDOSIS; MICROGLIA; NEURODEGENERATION; SYSTEMS BIOLOGY; TAUOPATHY;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MICE; MICROGLIA; RISK FACTORS;

EID: 84896332591     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.11.019     Document Type: Review

References (24)

1. J.O. Rinne, D.J. Brooks, M.N. Rossor, N.C. Fox, R. Bullock, and W.E. Klunk et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study Lancet Neurol 9 2010 363 372
2. S. Gandy, and S.T. DeKosky Toward the treatment and prevention of Alzheimer's disease: Rational strategies and recent progress Annu Rev Med 64 2013 367 383
3. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, and N.D. Tsopelas et al. Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
4. Gandy S, Ikonomovic MD, Mitsis E, Elder G, Ahlers ST, Barth J, et al. (in press): Chronic traumatic encephalopathy. Molecular Neurodegen.
5. P. Szabo, N. Relkin, and M.E. Weksler Natural human antibodies to amyloid beta peptide Autoimmun Rev 7 2008 415 420
6. M. Gold, D. Mengel, S. Röskam, R. Dodel, and J.P. Bach Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia J Neuroinflammation 10 2013 5
7. N. Kozauer, and R. Katz Regulatory innovation and drug development for early-stage Alzheimer's disease N Engl J Med 368 2013 1169 1171
8. M. Thambisetty, Y. An, M. Nalls, J. Sojkova, S. Swaminathan, and Y. Zhou et al. Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype Biol Psychiatry 73 2013 422 428
9. S. Gandy, V. Haroutunian, S.T. DeKosky, M. Sano, and E.E. Schadt CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease Biol Psychiatry 73 2013 393 395
10. K.R. Miller, and W.J. Streit The effects of aging, injury and disease on microglial function: A case for cellular senescence Neuron Glia Biol 3 2007 245 253
11. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, and E. Majounie et al. TREM2 variants in Alzheimer's disease N Engl J Med 368 2013 117 127
12. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, and J. Snaedal et al. Variant of TREM2 associated with the risk of Alzheimer's disease N Engl J Med 368 2013 107 116
13. B. Zhang, C. Gaiteri, L.G. Bodea, Z. Wang, J. McElwee, and A.A. Podtelezhnikov et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720
14. S.A. Grathwohl, R.E. Kälin, T. Bolmont, S. Prokop, G. Winkelmann, and S.A. Kaeser et al. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia Nat Neurosci 12 2009 1361 1363
15. J. vom Berg, S. Prokop, K.R. Miller, J. Obst, R.E. Kälin, and I. Lopategui-Cabezas et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline Nat Med 18 2012 1812 1819
16. Y. Zhu, H. Hou, K. Rezai-Zadeh, B. Giunta, A. Ruscin, and C. Gemma et al. CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice J Neurosci 31 2011 1355 1365
17. L. Bertram, C. Lange, K. Mullin, M. Parkinson, M. Hsiao, and M.F. Hogan et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE Am J Hum Genet 83 2008 623 632
18. A.C. Naj, G. Jun, G.W. Beecham, L.S. Wang, B.N. Vardarajan, and J. Buros et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Nat Genet 43 2011 436 441
19. A. Griciuc, A. Serrano-Pozo, A.R. Parrado, A.N. Lesinski, C.N. Asselin, and K. Mullin et al. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta Neuron 78 2013 631 643
20. M.T. Heneka, M.P. Kummer, A. Stutz, A. Delekate, S. Schwartz, and A. Vieira-Saecker et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice Nature 493 2013 674 678
21. J.T. Dudley, M. Sirota, M. Shenoy, R.K. Pai, S. Roedder, and A.P. Chiang et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease Sci Transl Med 3 2011 96ra76
22. S.H. Kim, P.E. Fraser, D. Westaway St, P.H. George-Hyslop, M.E. Ehrlich, and S. Gandy Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals J Neurosci 30 2010 3870 3875
23. S. Gandy, J.W. Steele, S.W. Lee, D. Clemenson, R. Gadient, and P. Wedel et al. WIP1104. Behavioral deficits in APP transgenic mice reversed by mGluR inhibitor with pro-neurogenic, Aβ-reducing, and anxiolytic properties [abstract] Ann Neurol 72 2012 S126
24. G. Krabbe, A. Halle, V. Matyash, J.L. Rinnenthal, G.D. Eom, and U. Bernhardt et al. Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology PLoS One 8 2013 e60921